KP
MRK icon

Keel Point’s Merck MRK Stock Holding History

Keel Point’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.74M Sell
39,387
-12,184
-24% -$1.41M 0.31% 48
2025
Q4 		$5.43M Sell
51,571
-9,252
-15% -$868K 0.33% 50
2025
Q3 		$5.1M Buy
60,823
+1,652
+3% +$136K 0.31% 51
2025
Q2 		$4.68M Buy
59,171
+6,841
+13% +$544K 0.31% 57
2025
Q1 		$4.7M Buy
52,330
+11,303
+28% +$1.06M 0.36% 48
2024
Q4 		$4.08M Sell
41,027
-228
-0.6% -$23.5K 0.33% 57
2024
Q3 		$4.68M Buy
41,255
+1,622
+4% +$193K 0.39% 47
2024
Q2 		$4.53M Buy
39,633
+897
+2% +$116K 0.41% 46
2024
Q1 		$5.11M Buy
38,736
+1,357
+4% +$167K 0.53% 33
2023
Q4 		$4.08M Sell
37,379
-361
-1% -$37.5K 0.49% 39
2023
Q3 		$3.89M Sell
37,740
-1,425
-4% -$154K 0.53% 34
2023
Q2 		$4.52M Sell
39,165
-2,216
-5% -$252K 0.6% 28
2023
Q1 		$4.4M Buy
41,381
+32,767
+380% +$3.54M 0.64% 26
2022
Q4 		$956K Buy
8,614
+748
+10% +$76.5K 0.15% 110
2022
Q3 		$677K Sell
7,866
-38
-0.5% -$3.39K 0.12% 116
2022
Q2 		$705K Buy
7,904
+992
+14% +$87.9K 0.11% 121
2022
Q1 		$567K Buy
6,912
+1,191
+21% +$93.9K 0.09% 138
2021
Q4 		$438K Buy
5,721
+469
+9% +$37.4K 0.05% 167
2021
Q3 		$394K Buy
5,252
+221
+4% +$16.8K 0.05% 165
2021
Q2 		$391K Sell
5,031
-132
-3% -$9.82K 0.04% 174
2021
Q1 		$380K Buy
5,163
+524
+11% +$38.7K 0.04% 181
2020
Q4 		$362K Buy
4,639
+111
+2% +$8.49K 0.03% 179
2020
Q3 		$358K Buy
+4,528
New +$355K 0.03% 165
2016
Q4 		– Sell
-3,672
Closed -$219K – 163
2016
Q3 		$219K Sell
3,672
-42
-1% -$2.46K 0.08% 121
2016
Q2 		$204K Buy
+3,714
New +$198K 0.09% 127
2015
Q3 		– Sell
-4,073
Closed -$226K – 107
2015
Q2 		$226K Buy
+4,073
New +$228K 0.11% 91

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Keel Point's MRK Position: Q1 2026 in Review

Keel Point reduced its Merck (MRK) stake by 24% in Q1 2026, selling an estimated $1.41M and leaving 39,387 shares worth $4.74M. The position accounts for 0.31% of the portfolio, ranked #48.

Keel Point first reported a position in MRK in Q2 2015 and has held it in 26 quarters since. The position peaked at $5.43M in Q4 2025. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Keel Point held 39,387 shares of Merck worth $4.74M as of Q1 2026.
  • Keel Point sold 12,184 Merck shares in Q1 2026, an estimated $1.41M.
  • Merck made up 0.31% of Keel Point's portfolio in Q1 2026, its #48 holding.
  • Keel Point first reported a position in Merck in Q2 2015 and has held it in 26 quarters since.
  • Keel Point's Merck position peaked at $5.43M in Q4 2025.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Keel Point's 13F filing for Q1 2026, filed 1 Jun 2026.